Table 4.

Multivariate analysis for progression free survival and overall survival.

	Progression-free survival			Overall survival
	HR	95% CI		HR	95% CI
Lung met.	1.22	[0.80–1.87]	p = 0.35	1.38	[0.88–2.18]	p = 0.17
Lymph-node met.	0.99	[0.69–1.42]	p = 0.97	1.25	[0.86–1.81]	p = 0.25
Bone met.	1.62	[0.88–2.99]	p = 0.12	1.69	[0.92–3.08]	p = 0.09
Liver met.	0.93	[0.63–1.36]	p = 0.69	1.07	[0.71–1.61]	p = 0.74
Leucocytes > 10	1.20	[0.83–1.75]	p = 0.33	1.54	[1.04–2.26]	p = 0.03
LDH > ULN	1.62	[1.09–2.39]	p = 0.02	1.26	[0.86–1.85]	p = 0.23
Age > 65	1.10	[0.75–1.60]	p = 0.64	1.00	[0.68–1.47]	p = 0.99
WHO PS 1–2	1.22	[0.85–1.74]	p = 0.29	1.67	[1.13–2.46]	p = 0.01
Gender (male)	1.14	[0.78–1.66]	p = 0.49	1.19	[0.81–1.74]	p = 0.38
No of met sites > 2	1.14	[0.78–1.66]	p = 0.49	1.12	[0.76–1.66]	p = 0.58

Bold values indicate statistical significance p value <0.05.

The tables demonstrate the results of the multivariate analysis for the progression free survival and overall survival.